A Non-Interventional Study of RAYOS in Adult Patients With Rheumatoid Arthritis

CompletedOBSERVATIONAL
Enrollment

75

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

October 31, 2015

Study Completion Date

October 31, 2015

Conditions
Rheumatoid Arthritis
Interventions
DRUG

RAYOS (delayed-release prednisone)

Physicians may prescribe any dosage of RAYOS based on what is appropriate for the treatment of the patient's condition as determined by performing standard of care assessments.

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Amgen

INDUSTRY

NCT02287610 - A Non-Interventional Study of RAYOS in Adult Patients With Rheumatoid Arthritis | Biotech Hunter | Biotech Hunter